Progress and prognosis in 9 patients after CP therapy (combination of cisplatin and peplomycin)

Junichi Asaumi, Shigeki Koyama, Keishi Tsuruta, Nobuyuki Ikegami, Katsumi Nishijima

研究成果査読

抄録

The effects and complications associated with cisplatin and peplomycin combination chemotherapy (CP therapy) are reported. Nine patients with head and neck cancer were treated as follows: cisplatin (75 mg/body) was administered by intravenous infusion continuously for 24 h, followed by continuous peplomycin (5 mg/body) intravenous infusion for 5 h per day for 2 or 6 days. A complete response (CR) was attained in 2 patients and a partial response (PR) in 5. Complications observed were: leukocytopenia (7), anemia (6), nausea or vomiting (4), renal disorder (4), fever (2), increased serum transaminase levels (6) and hair loss (3). It is concluded that CP therapy was effective and safe as neo-adjuvant treatment for patients with head and neck cancer.

本文言語English
ページ(範囲)166-173
ページ数8
ジャーナルORAL THERAPEUTICS AND PHARMACOLOGY
6
3
DOI
出版ステータスPublished - 1987

ASJC Scopus subject areas

  • 歯学一般
  • 薬理学
  • 薬理学(医学)

フィンガープリント

「Progress and prognosis in 9 patients after CP therapy (combination of cisplatin and peplomycin)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル